Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer. - Anobile DP; Barbar L; Maucotel E; Cornec A; Manriquez V; Richer W; Denizeau J; Sedlik C; Bories C; Couderc E; Leclere R; Sobas J; et al. (PLoS biology, 2026)